Bio Farma Ready to Supply Covid-19 Vaccine Up to 18 Million Doses

The arrival of bulk as much as six million doses today, will increase the supply of bulk vaccines to 65.5 million doses of the Covid-19 vaccine, and from that amount will be converted into finished products as much as approximately 52,800,000 million doses

(30/4) Parent Holding BUMN Pharmaceutical Bio Farma, ready to supply covid-19 vaccine between 16-18 million doses for next May. This followed the receipt of the tenth shipment of bulk Covid-19 vaccine on April 30, 2021 as many as six million doses from Sinovac.

In addition to bulk vaccine Sinovac, Holding BUMN Pharmaceuticals through its members, Kimia Farma, is scheduled to receive the first stage of the Covid-19 vaccine from other manufacturers namely Sinopharm, in the form of finished products as many as 482,400 doses.

Vaccine - vaccine that arrived at Cargo Soekarno - Hatta Airport at 12:05 PM received by the Minister of Communication and Information Johnny G Plate.

In his brief remarks Johnny said the arrival of vaccines today is a form of government consistency in securing vaccines in the country amid the situation of other countries in the world vying for vaccines.

"Today the covid19 vaccine has arrived a total of 6,000,000 doses in the form of raw materials or bulk derived from Sinovac Biotech Ltd. and 482,400 doses of vaccine in finished form from Sinopharm China National Pharmaceutical Corp. With the arrival of this tenth stage vaccine, we have received a total of 65,500,000 doses of vaccine in the form of raw materials or bulk and 8,448,000 doses of vaccine in finished form from Sinovac, Sinopharm, and Covax/Gavi Facility (AstraZeneca brand)", said Johny.

The arrival of vaccines is a form of government consistency in obtaining the supply of vaccines gradually in the midst of the situation of world countries racing to get the Covid-19 vaccine.

Corporate Secretary of Bio Farma and Spokesperson of Covid-19 Vaccine, Bambang Heriyanto said that the arrival of bulk as much as six million doses today, will increase the supply of bulk vaccine to 65.500.000 million doses of Covid-19 vaccine, and from that amount will be converted into finished products as much as approximately 52,800,000 million doses.

"Today (30/4), the total bulk of Covid-19 vaccine from Sinovac that has been received by Bio Farma as much as 65,500,000 million doses of vaccine. From this number, Bio Farma will produce gradually up to 52,800,000 million doses of the Covid-19 vaccine that is expected to be completed on May 22, 2021," he said.

As for the current process at the fill and finish facility in Bio Farma, still using bulk supply inventory week 3 of April 2021, which is as much as 59.5 million doses that will be the finish of the product as much as 46,000,000 - 47,000,000 doses, which until today, (30/4) the number of Covid-19 vaccines that have been successfully produced as many as 41,000,000 doses.

For the distribution of Covid-19 vaccine, it will be done after obtaining a lot release from pom agency. As of April 28, 2021, the number of Covid-19 vaccines that have been distributed is almost 22,500,000 million doses. This number is outside the CoronaVac vaccine as much as 3,000,000 doses and astrazeneca vaccine (Covax) as much as 1,113,600 doses that have been distributed previously.

"Bio Farma will continue to distribute the Covid-19 vaccine to all provinces in Indonesia in accordance with the instructions of the Ministry of Health. Until the date (30/4) has been more than 25,000,000 doses of the Covid-19 vaccine distributed to all provinces in Indonesia and will increase by 16,000,000 -18,000,000 doses in the coming May", Bambang said. (ed/ss)